Foresite Capital Management Competitors, Revenue, Alternatives and Pricing
Overview

Industry Ranking
Estimated Revenue & Financials
- Foresite Capital Management received $668.0M in venture funding in May 2018.
- Foresite Capital Management's total funding is $1.4B.
Employee Data
- Foresite Capital Management has 53 Employees.
- Foresite Capital Management grew their employee count by 2% last year.
- Foresite Capital Management currently has 1 job openings.
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
Advertise Here | ||||||
#1 | N/A | 32 | N/A | N/A | - | N/A |
#2 | N/A | 150 | 18% | N/A | - | N/A |
#3 | N/A | 234 | 7% | N/A | - | N/A |
#4 | N/A | 304 | N/A | N/A | - | N/A |
#5 | N/A | 125 | 0% | N/A | - | N/A |
#6 | N/A | 19 | N/A | N/A | - | N/A |
#7 | N/A | 18 | N/A | N/A | - | N/A |
#8 | N/A | 43 | 16% | N/A | - | N/A |
#9 | N/A | 19 | N/A | N/A | - | N/A |
#10 | N/A | 70 | 37% | N/A | - | N/A |
What Is Foresite Capital Management?
Foresite Capital is a multi-stage healthcare and life sciences investment firm that applies rigorous scientific and data-driven approaches to investment analysis. The firm has $2.2 billion in assets under management. Foresite Capital takes a collaborative approach to investing with its portfolio companies by providing a multidisciplinary team of scientists, engineers, analysts, and clinicians who understand the unique business models in healthcare in addition to capital. The company aims to address areas of great unmet clinical need over the long term by funding promising healthcare and life sciences businesses at all stages of their life cycles. Its portfolio also emphasizes companies that are employing the tools of data science and machine intelligence in healthcare. Foresite Capital is based in San Francisco with an office in New York.
keywords:Finance,Healthcare,Pharmaceuticals53
Number of Employees
N/A
Revenue (est)
1
Current Jobs
2%
Employee Growth %
$1.4B
Total Funding
N/A
Valuation
N/A
Accelerator
B2B
Type
Foresite Capital Management News
Aerie Pharmaceuticals Inc (NASDAQ:AERI) major shareholder Foresite Capital Management Ii bought 15,700 shares of the firm's stock in a ...
Foresite Capital Management III LLC reduced its position in shares of Immunomedics, Inc. (NASDAQ:IMMU) by 19.3% in the 2nd quarter, ...
Foresite Capital Management III LLC boosted its position in shares of Natera Inc (NASDAQ:NTRA) by 13.6% during the 2nd quarter, according ...
Foresite Capital Management Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2014-04-02 | $300.0M | Undisclosed | Article | |
2015-07-30 | $450.0M | Third | Article | |
2018-05-04 | $668.0M | Fourth | Limited partners in Fund IV | Article |
Foresite Capital Management Executive Hires
Date | Name | Title | Reference |
---|---|---|---|
2017-04-25 | Molly He | Venture Partner | Article |
2018-12-12 | Nick Smith | Head of investor relations | Article |